Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapyKenji Ishikura, Kazumoto Iijima, Hiroshi Kaito et al.|Clinical and Experimental Nephrology|2015Cited by 87
Mycophenolate Mofetil after Rituximab for Childhood-Onset Complicated Frequently-Relapsing or Steroid-Dependent Nephrotic SyndromeKazumoto Iijima, Mayumi Sako, Mari S. Oba et al.|Institutional Repositories DataBase (IRDB)|2022Cited by 57
Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapyYoshitsugu Kaku, Kazumoto Iijima, Yasufumi Ohtsuka et al.|Clinical and Experimental Nephrology|2015Cited by 46
Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)Kandai Nozu, Kazumoto Iijima, Mayumi Sako et al.|Clinical and Experimental Nephrology|2023Cited by 6
Rituximab-induced long-term remission in childhood-onset, uncomplicated, frequently relapsing or steroid-dependent nephrotic syndrome: a randomized, placebo-controlled trial and a follow-up studyKazumoto Iijima, Yosuke Inaguma, Mayumi Sako et al.|Scientific Reports|2025Cited by 5